Drug details:
Molecular formula: C₂₁H₁₂Cl₃NO₆S

Standard name: 3,5-dichloro-N-[2-(2-chlorophenyl)-5-hydroxy-4-oxochromen-8-yl]-2-hydroxybenzenesulfonamide

Curated SMILES: O=C1C=C(C2=CC=CC=C2Cl)OC2=C(NS(=O)(=O)C3=CC(Cl)=CC(Cl)=C3O)C=CC(O)=C12

Evidence for compound's anti-virulence activity:

Salmonella
Related VF: TTSS (SPI-2 encode)
Target: SseK1/SseK2
Drug effect: Inhibits SseK1/SseK2 Arg glycosyltransferase activity.
Max phase: Preclinical (in vitro)
Publication:
El Qaidi S, et al., 2018. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors. Front Cell Infect Microbiol 8:435.